Evidence map›Paper›PMID 38818748›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2024

Large hospital outbreak caused by OXA-244-producing

Radosław Izdebski, Marta Biedrzycka, Paweł Urbanowicz, Dorota Żabicka, Teresa Błauciak, Dorota Lechowicz, Beata Gałecka-Ziółkowska, Marek Gniadkowski

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Rapidly spreadingJournal of clinical microbiology · 2025
    Review
  2. Review
  3. Several epidemic and multiple sporadic genotypes of OXA-244-producing Escherichia coli in Poland; predominance of the ST38 clone.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Radosław IzdebskiDepartment of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
Marta BiedrzyckaDepartment of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
Paweł UrbanowiczDepartment of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
Dorota ŻabickaNational Reference Centre for Susceptibility Testing, Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland.
Teresa BłauciakBacteriological and Serological Laboratory, Multispecialist Hospital, Nowa Sól, Poland.
Dorota LechowiczHospital Infection Control and Prevention Team, Multispecialist Hospital, Nowa Sól, Poland.
Beata Gałecka-ZiółkowskaHospital Infection Control and Prevention Team, Multispecialist Hospital, Nowa Sól, Poland.
Marek GniadkowskiDepartment of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In February 2023,

Indexed as

Anti-Bacterial Agentsbeta-LactamasesCross InfectionDisease OutbreaksEscherichia coliEscherichia coli InfectionsMicrobial Sensitivity TestsWhole Genome SequencingDrug Resistance, Multiple, BacterialHumansPolandAnti-Bacterial Agentsbeta-LactamasesEscherichia coliOXA-244PolandST38

Identifiers

PMID38818748
PMCPMC11141128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.